153 related articles for article (PubMed ID: 7490514)
1. Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models.
Hubsch AP; Casas AT; Doran JE
J Lab Clin Med; 1995 Dec; 126(6):548-58. PubMed ID: 7490514
[TBL] [Abstract][Full Text] [Related]
2. Effects of reconstituted high-density lipoprotein in persistent gram-negative bacteremia.
Casas AT; Hubsch AP; Doran JE
Am Surg; 1996 May; 62(5):350-5. PubMed ID: 8615560
[TBL] [Abstract][Full Text] [Related]
3. Reconstituted high-density lipoprotein reduces LPS-stimulated TNF alpha.
Casas AT; Hubsch AP; Rogers BC; Doran JE
J Surg Res; 1995 Nov; 59(5):544-52. PubMed ID: 7475000
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.
Saladino R; Garcia C; Thompson C; Hammer B; Parsonnet J; Novitsky T; Siber G; Fleisher G
Circ Shock; 1994 Feb; 42(2):104-10. PubMed ID: 8013061
[TBL] [Abstract][Full Text] [Related]
5. Endotoxin-induced mortality in bile duct-ligated rats after administration of reconstituted high-density lipoprotein.
Sewnath ME; Levels HH; Oude Elferink R; van Noorden CJ; ten Kate FJ; van Deventer SJ; Gouma DJ
Hepatology; 2000 Dec; 32(6):1289-99. PubMed ID: 11093736
[TBL] [Abstract][Full Text] [Related]
6. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
Calandra T; Baumgartner JD; Glauser MP
Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
[TBL] [Abstract][Full Text] [Related]
7. Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock.
McDonald MC; Dhadly P; Cockerill GW; Cuzzocrea S; Mota-Filipe H; Hinds CJ; Miller NE; Thiemermann C
Shock; 2003 Dec; 20(6):551-7. PubMed ID: 14625480
[TBL] [Abstract][Full Text] [Related]
8. Infusion of lipoproteins into volunteers enhances the growth of Candida albicans.
Netea MG; Curfs JH; Demacker PN; Meis JF; Van der Meer JW; Kullberg BJ
Clin Infect Dis; 1999 May; 28(5):1148-51. PubMed ID: 10452650
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.
Quezado ZM; Natanson C; Banks SM; Alling DW; Koev CA; Danner RL; Elin RJ; Hosseini JM; Parker TS; Levine DM
J Pharmacol Exp Ther; 1995 Feb; 272(2):604-11. PubMed ID: 7853173
[TBL] [Abstract][Full Text] [Related]
10. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
[TBL] [Abstract][Full Text] [Related]
12. Reconstituted high density lipoprotein inhibits physiologic and tumor necrosis factor alpha responses to lipopolysaccharide in rabbits.
Cué JI; DiPiro JT; Brunner LJ; Doran JE; Blankenship ME; Mansberger AR; Hawkins ML
Arch Surg; 1994 Feb; 129(2):193-7. PubMed ID: 8304830
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
[TBL] [Abstract][Full Text] [Related]
14. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
[TBL] [Abstract][Full Text] [Related]
15. Reconstituted high density lipoprotein (rHDL) modulates platelet activity in vitro and ex vivo.
Lerch PG; Spycher MO; Doran JE
Thromb Haemost; 1998 Aug; 80(2):316-20. PubMed ID: 9716159
[TBL] [Abstract][Full Text] [Related]
16. Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
Opal SM; Palardy JE; Parejo N; Morrison DC
J Endotoxin Res; 2001; 7(1):35-8. PubMed ID: 11521079
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
[TBL] [Abstract][Full Text] [Related]
18. Renal interleukin-1 expression during endotoxemia and gram-negative septicemia in conscious rats.
Laszik Z; Nadasdy T; Johnson LD; Lerner MR; Brackett D; Silva FG
Circ Shock; 1994 Jul; 43(3):115-21. PubMed ID: 7850931
[TBL] [Abstract][Full Text] [Related]
19. Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
Giamarellos-Bourboulis EJ; Baziaka F; Antonopoulou A; Koutoukas P; Kousoulas V; Sabracos L; Panagou C; Perrea D; Giamarellou H
Int J Antimicrob Agents; 2005 Feb; 25(2):168-72. PubMed ID: 15664488
[TBL] [Abstract][Full Text] [Related]
20. High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.
Saladino RA; Stack AM; Thompson C; Sattler F; Novitsky TJ; Siber GR; Fleisher GR
Crit Care Med; 1996 Jul; 24(7):1203-7. PubMed ID: 8674336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
